glp 1 for non obese GLP-1 Agonists In Obesity Long-term Success of GLP-1s Hinges

They also protect against ROS.The L form is used because the D form is not used in body

I dont see anyone else laughing Elon)

These drugs induce a mean weight loss of 1.88kg and also lower blood pressure (mean: 2.46mmHg in systolic and 1.46mmHg in diastolic blood pressure).48 The EMPA-REG,49 CANVAS and CANVAS-R trials,50 conducted in patients with DM2 and high cardiovascular risk, showed empagliflozin and canagliflozin to reduce cardiovascular risk (including cardiovascular death, non-fatal myocardial infarction or non-fatal stroke, and hospital admission due to heart failure)

For reference, 3% minoxidil the standard OTC strength was outperformed in the same study population

Important Note: These potential benefits are based primarily on animal data and anecdotal use, not clinical trials in women

Structurally similar to GLP-1 but unaffected by DPP-4, this peptide lingers in the blood for hours rather than minutes